Literature DB >> 26916291

Coronary endothelial dysfunction is associated with increased risk of venous thromboembolism.

Megha Prasad1, Robert McBane1, Martin Reriani1, Lilach O Lerman1, Amir Lerman2.   

Abstract

BACKGROUND: Normal endothelial function is central to physiologic anticoagulation mechanisms. Endothelial dysfunction may predispose to venous thromboembolism (VTE). We aimed to investigate if coronary endothelial dysfunction (CED) predicts development of VTE in patients presenting with coronary atherosclerosis without critical stenoses.
METHODS: Coronary microvascular function was evaluated in 502 patients with coronary atherosclerosis without critical stenoses by administration of intracoronary acetylcholine at the time of diagnostic study. After a median follow-up of 6.3years, patients were assessed for the development of VTE by administration of a questionnaire. Coronary microvascular endothelial dysfunction was defined as ≤50% increase in coronary blood flow from baseline in response to maximal dose of acetylcholine.
RESULTS: The median age was 53years (IQR: 45, 62) 68% were female and CED occurred in 279 (56%) patients. Hypertension (40.8%), diabetes (8.4%), and hyperlipidemia (58.3%) were common risk factors. There were no differences in baseline characteristics between those with and without CED. There were 9 VTE events (6 unprovoked) among patients with CED compared to no events in the control group (P=0.01). DISCUSSION: CED was associated with the development of VTE. Endothelial injury by causing disruption of vascular hemostasis may play a role in predisposing patients to VTE.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26916291     DOI: 10.1016/j.thromres.2015.12.024

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.

Authors:  Megha Prasad; Eric L Matteson; Joerg Herrmann; Rajiv Gulati; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

2.  Significant role of long non-coding RNA MALAT1 in deep vein thrombosis via the regulation of vascular endothelial cell physiology through the microRNA-383-5p/BCL2L11 axis.

Authors:  Hecheng Wang; Shusen Lin; Yujie Yang; Mingyu Zhao; Xichun Li; Lanli Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Triglyceride and Triglyceride/ HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease.

Authors:  Megha Prasad; Jaskanwal Sara; Robert J Widmer; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

Review 4.  Good Fences Make Good Neighbors: Human Immunodeficiency Virus and Vascular Disease.

Authors:  Elizabeth S Mayne; Susan Louw
Journal:  Open Forum Infect Dis       Date:  2019-06-25       Impact factor: 3.835

Review 5.  Potential mechanisms of cerebrovascular diseases in COVID-19 patients.

Authors:  Manxue Lou; Dezhi Yuan; Shengtao Liao; Linyan Tong; Jinfang Li
Journal:  J Neurovirol       Date:  2021-02-03       Impact factor: 2.643

6.  From ACE2 to COVID-19: A multiorgan endothelial disease.

Authors:  Richard A Stein; Lauren M Young
Journal:  Int J Infect Dis       Date:  2020-09-05       Impact factor: 3.623

Review 7.  Elevated Risk of Venous Thromboembolism in People Living with HIV.

Authors:  Quan Zhang; Fei Peng; Meizhi Li; Qiong Yi; Wei Tang; Shangjie Wu
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

8.  Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.

Authors:  Darae Ko; Sarah R Preis; Andrew D Johnson; Ramachandran S Vasan; Emelia J Benjamin; Naomi M Hamburg; Gary F Mitchell
Journal:  Thromb Res       Date:  2021-06-19       Impact factor: 10.407

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.